Beclometasone/formoterol
Inhalable drug / From Wikipedia, the free encyclopedia
Beclometasone/formoterol, sold under the brand name Fostair, is an inhalable fixed-dose combination drug for the treatment of asthma and chronic obstructive pulmonary disease (COPD).[1] It contains beclometasone dipropionate and formoterol fumarate dihydrate. It is inhaled.[1]
Quick Facts Combination of, Formoterol fumarate ...
Combination of | |
---|---|
Beclometasone dipropionate | Glucocorticoid |
Formoterol fumarate | Long-acting β2 agonist |
Clinical data | |
Trade names | Fostair |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Inhalation |
ATC code | |
Legal status | |
Legal status |
Close
It was approved for medical use in the United Kingdom in 2007,[1] and in Australia in February 2020.[4][5] It is on the World Health Organization's List of Essential Medicines.[6]